Ida Hilden

Malov, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

A factor VIIIa-mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice.

A factor VIIIa-mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice.

Journal: Blood

Published: December 10, 2020

Thrombin generation potential in the presence of concizumab and rFVIIa, APCC, rFVIII, or rFIX: In vitro and ex vivo analyses.

Thrombin generation potential in the presence of concizumab and rFVIIa, APCC, rFVIII, or rFIX: In vitro and ex vivo analyses.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 09, 2020

Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and Protein S in people with haemophilia.

Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and Protein S in people with haemophilia.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: June 24, 2019

Concizumab promotes haemostasis via a tissue factor-factor VIIa-dependent mechanism supporting prophylactic treatment of haemophilia: Results from a rabbit haemophilia bleeding model.

Concizumab promotes haemostasis via a tissue factor-factor VIIa-dependent mechanism supporting prophylactic treatment of haemophilia: Results from a rabbit haemophilia bleeding model.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: June 04, 2019

Enhanced potency of recombinant factor VIIa with increased affinity to activated platelets.

Enhanced potency of recombinant factor VIIa with increased affinity to activated platelets.

Journal: Journal of thrombosis and haemostasis : JTH

Published: February 26, 2019

Administration of recombinant FVIIa (rFVIIa) to concizumab-dosed monkeys is safe, and concizumab does not affect the potency of rFVIIa in hemophilic rabbits.

Administration of recombinant FVIIa (rFVIIa) to concizumab-dosed monkeys is safe, and concizumab does not affect the potency of rFVIIa in hemophilic rabbits.

Journal: Journal of thrombosis and haemostasis : JTH

Published: September 27, 2018

Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S.

Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S.

Journal: Research and practice in thrombosis and haemostasis

Published: January 23, 2018

TFPIα interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation.

TFPIα interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation.

Journal: Blood advances

Published: January 02, 2018

Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain.

Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain.

Journal: Journal of thrombosis and haemostasis : JTH

Published: July 16, 2017

Concizumab, an anti-tissue factor pathway inhibitor antibody, induces increased thrombin generation in plasma from haemophilia patients and healthy subjects measured by the thrombin generation assay.

Concizumab, an anti-tissue factor pathway inhibitor antibody, induces increased thrombin generation in plasma from haemophilia patients and healthy subjects measured by the thrombin generation assay.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: March 29, 2017

Thrombin generation assay using factor XIa to measure factors VIII and IX and their glycoPEGylated derivatives is robust and sensitive.

Thrombin generation assay using factor XIa to measure factors VIII and IX and their glycoPEGylated derivatives is robust and sensitive.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 17, 2014

Inhibitory effects of LDL-associated tissue factor pathway inhibitor.

Inhibitory effects of LDL-associated tissue factor pathway inhibitor.

Journal: Thrombosis research

Published: February 04, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026